HUP0300685A3 - Method for reducing exacerbations associated with copd - Google Patents
Method for reducing exacerbations associated with copdInfo
- Publication number
- HUP0300685A3 HUP0300685A3 HU0300685A HUP0300685A HUP0300685A3 HU P0300685 A3 HUP0300685 A3 HU P0300685A3 HU 0300685 A HU0300685 A HU 0300685A HU P0300685 A HUP0300685 A HU P0300685A HU P0300685 A3 HUP0300685 A3 HU P0300685A3
- Authority
- HU
- Hungary
- Prior art keywords
- copd
- exacerbations associated
- reducing exacerbations
- reducing
- exacerbations
- Prior art date
Links
- 230000005713 exacerbation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22127500P | 2000-07-27 | 2000-07-27 | |
| PCT/US2001/023542 WO2002009689A1 (en) | 2000-07-27 | 2001-07-26 | Method for reducing exacerbations associated with copd |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0300685A2 HUP0300685A2 (en) | 2003-12-29 |
| HUP0300685A3 true HUP0300685A3 (en) | 2004-10-28 |
Family
ID=22827112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300685A HUP0300685A3 (en) | 2000-07-27 | 2001-07-26 | Method for reducing exacerbations associated with copd |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1320361A4 (en) |
| JP (1) | JP2004505039A (en) |
| KR (1) | KR20030019620A (en) |
| CN (1) | CN1444476A (en) |
| AR (1) | AR029984A1 (en) |
| AU (2) | AU2001279023B2 (en) |
| BR (1) | BR0112682A (en) |
| CA (1) | CA2417336A1 (en) |
| CZ (1) | CZ2003141A3 (en) |
| HU (1) | HUP0300685A3 (en) |
| IL (1) | IL153919A0 (en) |
| MX (1) | MXPA03000714A (en) |
| NO (1) | NO20030332D0 (en) |
| PL (1) | PL365612A1 (en) |
| WO (1) | WO2002009689A1 (en) |
| ZA (1) | ZA200300476B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (en) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
| US7776315B2 (en) | 2000-10-31 | 2010-08-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and additional active ingredients |
| DE10110772A1 (en) * | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics and PDE-IV inhibitors |
| GB0118373D0 (en) * | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| DE10230769A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on new anticholinergics and PDE-IV inhibitors |
| BRPI0406427B8 (en) | 2003-03-10 | 2021-05-25 | Astrazeneca Ab | process for preparing roflumilast |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| KR102087661B1 (en) * | 2018-07-27 | 2020-03-11 | 강원대학교산학협력단 | Composition for prevention or treatment of chronic obstructive pulmonary disease comprising GEBR-7B compound |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DZ3019A1 (en) * | 1999-03-01 | 2005-05-20 | Smithkline Beecham Corp | Use of a pde4 inhibitor in the preparation of a drug against copd. |
| SE9902937D0 (en) * | 1999-08-18 | 1999-08-18 | Astra Pharma Prod | Pharmaceutical compositions |
| CZ20021443A3 (en) * | 1999-10-29 | 2003-01-15 | Smithkline Beecham Corporation | Administration method of phosphodiesterase 4 inhibitor |
-
2001
- 2001-07-25 AR ARP010103546A patent/AR029984A1/en not_active Application Discontinuation
- 2001-07-26 CA CA002417336A patent/CA2417336A1/en not_active Abandoned
- 2001-07-26 AU AU2001279023A patent/AU2001279023B2/en not_active Ceased
- 2001-07-26 MX MXPA03000714A patent/MXPA03000714A/en unknown
- 2001-07-26 JP JP2002515242A patent/JP2004505039A/en not_active Withdrawn
- 2001-07-26 EP EP01957262A patent/EP1320361A4/en not_active Withdrawn
- 2001-07-26 BR BR0112682-2A patent/BR0112682A/en not_active IP Right Cessation
- 2001-07-26 KR KR10-2003-7001144A patent/KR20030019620A/en not_active Withdrawn
- 2001-07-26 WO PCT/US2001/023542 patent/WO2002009689A1/en not_active Ceased
- 2001-07-26 PL PL01365612A patent/PL365612A1/en not_active Application Discontinuation
- 2001-07-26 AU AU7902301A patent/AU7902301A/en active Pending
- 2001-07-26 HU HU0300685A patent/HUP0300685A3/en unknown
- 2001-07-26 CN CN01813330A patent/CN1444476A/en active Pending
- 2001-07-26 CZ CZ2003141A patent/CZ2003141A3/en unknown
- 2001-07-26 IL IL15391901A patent/IL153919A0/en unknown
-
2003
- 2003-01-17 ZA ZA200300476A patent/ZA200300476B/en unknown
- 2003-01-22 NO NO20030332A patent/NO20030332D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL153919A0 (en) | 2003-07-31 |
| NO20030332L (en) | 2003-01-22 |
| CN1444476A (en) | 2003-09-24 |
| EP1320361A4 (en) | 2006-04-05 |
| CZ2003141A3 (en) | 2004-07-14 |
| HUP0300685A2 (en) | 2003-12-29 |
| ZA200300476B (en) | 2004-04-23 |
| NO20030332D0 (en) | 2003-01-22 |
| AU7902301A (en) | 2002-02-13 |
| KR20030019620A (en) | 2003-03-06 |
| PL365612A1 (en) | 2005-01-10 |
| JP2004505039A (en) | 2004-02-19 |
| MXPA03000714A (en) | 2003-06-04 |
| AU2001279023B2 (en) | 2005-11-10 |
| WO2002009689A1 (en) | 2002-02-07 |
| AR029984A1 (en) | 2003-07-23 |
| BR0112682A (en) | 2003-06-24 |
| EP1320361A1 (en) | 2003-06-25 |
| CA2417336A1 (en) | 2002-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0000129D0 (en) | Components for roof assemblies | |
| PL352836A1 (en) | Clamp fitting for fastening glass panels | |
| PL348858A1 (en) | Method for producing l-phenylephrine hydrochloride | |
| AU7090201A (en) | Method | |
| AU7902301A (en) | Method for reducing exacerbations associated with copd | |
| IL134626A0 (en) | Test structure for metal cmp process control | |
| PL361146A1 (en) | Method for producing isocyanato-organosilanes | |
| IL144992A0 (en) | Method for treating copd | |
| HUP0102967A3 (en) | Method for producing organosilylalkyl-polysulphanes | |
| EP1245548A4 (en) | Method for preparing glass-ceramic | |
| IL137104A0 (en) | Method for treating copd | |
| EP1440234A4 (en) | Method and means for injecting fuel | |
| HK1057696A (en) | Method for reducing exacerbations associated with copd | |
| EP1365967A4 (en) | Means for carrying bottles | |
| AU7265900A (en) | Method for producing otoplastics | |
| GB2377957B (en) | Method for improving well quality | |
| HU0105202D0 (en) | Method for datatransmission | |
| TW453259U (en) | Structure for manual pincer | |
| GB0019822D0 (en) | Method and means for additional carriage space | |
| AU2002255185A8 (en) | Method for teaching fractions | |
| TW516589U (en) | Structure for setting component equipped with hanging tool | |
| TW448914U (en) | Capping structure for vase | |
| GB0027774D0 (en) | Alignment method | |
| HU9902898D0 (en) | Method for influancing thermosensibility | |
| GB0402085D0 (en) | Method for improving well quality |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |